Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins - Université de Picardie Jules Verne Accéder directement au contenu
Article Dans Une Revue Toxins Année : 2021

Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins


Chronic kidney disease (CKD) is a highly prevalent condition and is associated with a high comorbidity burden, polymedication, and a high mortality rate. A number of conventional and nonconventional risk factors for comorbidities and mortality in CKD have been identified. Among the nonconventional risk factors, uremic toxins are valuable therapeutic targets. The fact that some uremic toxins are gut-derived suggests that intestinal chelators might have a therapeutic effect. The phosphate binders used to prevent hyperphosphatemia in hemodialysis patients act by complexing inorganic phosphate in the gastrointestinal tract but might conceivably have a nonspecific action on gut-derived uremic toxins. Since phosphorous is a major nutrient for the survival and reproduction of bacteria, changes in its intestinal concentration may impact the gut microbiota's activity and composition. Furthermore, AST-120 is an orally administered activated charcoal adsorbent that is widely used in Asian countries to specifically decrease uremic toxin levels. In this narrative review, we examine the latest data on the use of oral nonspecific and specific intestinal chelators to reduce levels of gut-derived uremic toxins.
Fichier principal
Vignette du fichier
toxins-13-00091.pdf (352.26 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03572443 , version 1 (30-05-2022)




Solene M. Laville, Ziad A. Massy, Saïd Kamel, Jean Marc Chillon, Gabriel Choukroun, et al.. Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins. Toxins, 2021, 13 (2), pp.91. ⟨10.3390/toxins13020091⟩. ⟨hal-03572443⟩
33 Consultations
60 Téléchargements



Gmail Mastodon Facebook X LinkedIn More